448
Participants
Start Date
December 18, 2013
Primary Completion Date
August 31, 2017
Study Completion Date
August 31, 2018
medication for opioid use disorder
This is an open-label study. The project proposes to enroll up to 500 opiate dependent individuals entering Medication Assisted Treatment (Methadone or buprenorphine/naloxone) at Go Vap Clinic, HCMC, Vietnam. All participants who appear to meet inclusion criteria and who express interest in drug treatment will be invited to be screened for participation in the research. All participants will receive BDRC sessions (weekly for 12 weeks, monthly thereafter until week 52).
National Institute of Drug Abuse
FED
Expertise France
OTHER
University of Pennsylvania
OTHER